← Back to Clinical Trials
Recruiting NCT02550236

NCT02550236 LIFE Child (LIFE Leipzig Research Centre for Civilization Diseases)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02550236
Status Recruiting
Phase
Sponsor University of Leipzig
Condition Child Development
Study Type OBSERVATIONAL
Enrollment 7,000 participants
Start Date 2010-10
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 0 Years
Max Age 20 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 7,000 participants in total. It began in 2010-10 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Leipzig Research Centre for Civilization Diseases (LIFE) Child Study is a prospective longitudinal population-based study with a life course approach to health and disease. The LIFE Child Study focuses on two main research objectives: * What are premises of normal growth, development and health in children? * Which factors contribute to the development of non-communicable diseases such as childhood obesity and its co-morbidities, atopy and mental health problems? Detailed assessments will be conducted alongside long-term storage of biological samples in 1,000 pregnant women and more than 5,000 children and their families.

Eligibility Criteria

Inclusion Criteria: * children with their families and pregnant women of the area of Leipzig Exclusion Criteria: * severe diseases

Contact & Investigator

Central Contact

Antje Körner, Prof., MD

✉ antje.koerner@medizin.uni-leipzig.de
Principal Investigator

Antje Körner, Prof., MD

PRINCIPAL INVESTIGATOR

University of Leipzig

Frequently Asked Questions

Who can join the NCT02550236 clinical trial?

This trial is open to participants of all sexes, aged 0 Years or older, up to 20 Years, studying Child Development. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02550236 currently recruiting?

Yes, NCT02550236 is actively recruiting participants. Contact the research team at antje.koerner@medizin.uni-leipzig.de for enrollment information.

Where is the NCT02550236 trial being conducted?

This trial is being conducted at Leipzig, Germany.

Who is sponsoring the NCT02550236 clinical trial?

NCT02550236 is sponsored by University of Leipzig. The principal investigator is Antje Körner, Prof., MD at University of Leipzig. The trial plans to enroll 7,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology